ContentslistsavailableatScienceDirect
Reproductive Toxicology
jo u r n al h om ep age :w w w . e l s e v i e r . c o m / l o c a t e / r e p r o t o x
Major differences in the levels of redox status and antioxidant defence markers in the erythrocytes of pre- and full-term neonates with
intrauterine growth restriction
Ágnes Ferencz
a, Hajnalka Orvos
b, Edit Hermesz
a,∗aDepartmentofBiochemistryandMolecularBiology,FacultyofScienceandInformatics,P.O.Box533,H-6701Szeged,Hungary
bDepartmentofObstetricsandGynaecology,UniversityofSzeged,P.O.Box533,H-6701Szeged,Hungary
a r t i c l e i n f o
Articlehistory:
Received30September2014
Receivedinrevisedform16February2015 Accepted17February2015
Availableonline24February2015
Keywords:
Antioxidantdefence IUGR
Oxidativestress Peroxynitrite Umbilicalcordblood
a b s t r a c t
Intrauterinegrowthrestriction(IUGR)isapleiotropiccomplicationofpregnancy.Prematurityandgrowth abnormalitiesarecommonriskfactorsforperinatalmorbidityandmortality.Freeradicaldamagehas beenrecognizedasacommonpathogenicmechanismofmanyneonataldiseases.Theaimofthepresent studywastocharacterizethepossiblelinksbetweenthelevelofmaturity,thebirthweightandthe antioxidantstatusofneonatesbornwithIUGR.Ourdatasuggestthatthestressmarkersmeasuredon thecordbloodofneonateswithIUGRandmature,healthyneonatesdonotnecessarilyreflecttheextent ofoxidativestress.However,significantcorrelationswerefoundbetweenthematurityoftheneonates withIUGRandtheoxidativedamage.ThematureIUGRsexhibitedONOO−accumulationandincreased lipidperoxidationmorefrequentlyascomparedwiththepre-termgroup.Theresultssuggestthatthe oxidativeinjuryinIUGRmaydependonthelevelofmaturityandthebirthweight.
©2015ElsevierInc.Allrightsreserved.
1. Introduction
Pregnancyisaphysiologicalstateassociatedwithanenhanced metabolism and an increased demand for oxygen. Premature infants are at particular risk from oxidative stress, as neither theendogenous northe passively acquiredexogenous antioxi- dantdefencesystemaccelerates inmaturationuntil late inthe third trimester [1,2]. Intrauterine growth restriction (IUGR) is one of themajor complications of pregnancy and accounts for significant neonatal mortality and morbidity [3]. The develop- mentofIUGRmaybeaconsequenceofvariousfactors,including an abnormal fetomaternal blood circulation, genetic disorders, pregnancy-inducedhypertension,pregestationaldiabetes,alean umbilicalcord,previousintrauterineinfections,apoornutritional stateofthemother,frequentcigarettesmoking[4]andtoxinor drugexposure[5].However,inthevastmajorityofthecasesthe causeremainsidiopathic.
IUGRis often complicated by intrauterinehypoxia and may inducethegenerationofreactiveoxygenspecies(ROS)andfoetal oxidativestress,resultinginseriousconsequencesforthefoetus, suchaslowbirthweightandprematurity[6].NeonateswithIUGR
∗Correspondingauthor.Tel.:+3662544887;fax:+3662544887.
E-mailaddress:hermesz@bio.u-szeged.hu(E.Hermesz).
aremoresusceptibletoROS-inducedoxidativedamagebecause theirenzymaticandnon-enzymaticantioxidantdefencesystems andtheabilitytoundergoinductionduringahyperoxicchallenge areimpaired[7].
To eliminate the harmful effects of ROS, cells are equipped withanefficientantioxidantdefencesystem,includingenzymes suchas superoxide dismutase (SOD), catalase (CAT),hemeoxy- genases (HOs),and low-molecular weightantioxidants suchas glutathione (GSH)and metallothioneins (MTs) [8,9]. SOD catal- yses thereduction of thesuperoxide anion (O2˙−)tohydrogen peroxide(H2O2).Inasubsequentstep,CATstimulatesthedegra- dationofH2O2tomolecularoxygenandwater[10].TheMTsare smallproteinswithunusuallyhighcysteinecontent.Thisconfers theirhighmetal-bindingand ROS-reducingproperties[11].The HOsplayrolesinhemedegradation,yieldingequimolarquantities ofbiliverdin,carbonmonoxide(CO)withimportantfreeradical- scavenging properties and free Fe ions. In mature neonates, a considerableproportionoftheplasmatotalantioxidantcapacity originatesfrombilirubin[12].HO-2isaconstitutive,andHO-1an inducibleisoformofHO,anantioxidative,anti-inflammatoryand cytoprotectiveenzymethatisinducedinresponsetocellularstress, includingoxidativestress[13].
Nitricoxide(NO)maybeanimportantfactorfortheregulation ofbloodpressureandoxygendeliverytothefoetus[14].Umbili- calcordbloodvesselslackinnervations,andendothelialcellsmust http://dx.doi.org/10.1016/j.reprotox.2015.02.008
0890-6238/©2015ElsevierInc.Allrightsreserved.
Table1
Clinicalparametersofthestudygroupsandthematernalage.Dataareexpressedasmeans±SD.Theminimumandthemaximumvaluesoftheparametersaregivenin parentheses.
Full-termneonateswithnormalweight Full-termneonateswithIUGR Pre-matureneonateswithIUGR Gestationalageatdelivery(weeks) 39.2±0.77(38–40+2) 38.741.31(37–40+4) 34.01±1.62(30–36)
Birthweight(g) 3409±455(3190–4340) 2354238.8(2090–2490) 1518±460.5(980–2120)
ThepHofbloodsamples 7.25±0.11(7.04–7.42) 7.240.088(7.1–7.36) 7.20±0.142(7.05–7.3)
1minAPGAR 8.83±1.37(6–10) 8.361.65(6–10) 7±1.63(4–9)
Maternalage(years) 29.9±5.74(22–42) 28.96.55(20–41) 29.3±7.22(21–42)
thereforeplayamajorroleinthelocalcontrolofbloodflow[15].
NOderivedfromendothelialnitricoxidesynthase(eNOS)isconsid- eredthemainvasodilatoragentinfetoplacentalvessels[16].The simultaneousgenerationofNOandO2˙−insufficientlyhighcon- centrationsinthesamecompartmentfavourstheproductionofa toxicreactionproduct,peroxynitriteanion(ONOO−).ONOO−and otherreactivenitrogenspeciescanaffectthecellfunctionsthrough theoxidationornitrationofvariouscellulartargets[17].
Understressconditions,genescodingformoleculesinvolved inbiologicaldefenceandcellularrepairaremarkedlyupregulated, andthechangesingeneexpressioncanbecharacteristic,sensi- tiveandmeasurableendpoints[18].Membersofthisantioxidant defencesystemareusefulbiomarkersoftheoxidant–antioxidant statusofneonateswithIUGR.Theaimofthepresentstudywas tocharacterizethepossiblelinksbetweenthelevelofmaturity, thebirthweightandtheantioxidantstatusofneonatesbornwith IUGR.Wereportdataonmacromoleculardamage,theaccumula- tionofpowerfuloxidantssuchONOO−,H2O2,theactivitiesofthe antioxidantenzymesSODandCAT,andtheexpressionsofaset ofgenescodingformembersofantioxidantdefencesystem(sod1, sod2,cat,mt-1,mt-2,ho-1,ho-2andenos)fromtheaspectsofthe levelofmaturityandthebirthweightofneonateswithIUGR.
2. Materialsandmethods 2.1. Humansubjects
The blood samples were obtained from the Department of ObstetricsandGynaecologyattheUniversityofSzeged,Hungary.
The Ethics Committee of the Department of Obstetrics and Gynaecologyapprovedthestudyprotocol(149/2012).24mature neonateswithnormalweightand28matureand28premature neonateswithIUGRofeithersexwereexamined.Theneonates wereconsideredprematureiftheywerebornbeforethegesta- tionalageof37weeksandfull-termifthedeliveryoccurredafter37 weeks.Newbornsthathadahistoryofdifficultdeliveryandfoetal distress,orshowedmalformationsorevidenceofgeneticdisorders wereexcluded.Thenutritionalstatusofthemothersduringpreg- nancywassatisfactory;nocaseofmalnutritionoccurred.Smoking mothersandtheirneonateswerealsoexcludedfromthisstudy.
Bloodwastakenfromtheumbilicalartery,beforethebirthof theplacenta.BloodcoagulationwasinhibitedbyEDTA.Theblood sampleswerecentrifugedat3000rpmfor20minat4◦C,andthe plasmaandthebuffycoatwereremoved.Theredbloodcell(RBC) phasewaswashedtwicewith2volumesofisotonicsalinesolu- tionatpH7.0.Thesampleswerestoredat−80◦Cuntilprocessing (Table1).
2.2. RNAextraction,reversetranscriptionandPCRamplification
Approximately,100mgoffrozenRBCwerehomogenizedinRNA Beereagent(Tel-Test,Inc.)andtotalRNAswerepreparedaccord- ingtotheproceduresuggestedbythemanufacturer.TotalRNAwas routinelytreatedwith100URNAse-freeDNAseI(ThermoScien- tific)toavoidanyDNAcontamination.
For the quantification of mt-1and mt-2,sod1 and sod2, cat, enos,ho-1and ho-2mRNAs,reverse transcription followedPCR amplifications(RT-PCRs)wereperformed.First-strandcDNAswere synthesizedbyusing5gtotalRNAsastemplates,200pmolof each dNTP(ThermoScientific),200UMaximaH MinusReverse Transcriptase(ThermoScientific)and500pmolrandomhexamer primers(Sigma)inafinalvolumeof20L,andincubatedfor10min at37◦C,followedby1hat52◦C.Onemicroliterreversetranscrip- tionproductwasaddedto25LDreamTaqGreenPCRMasterMix 2x(ThermoScientific).AmplificationwasperformedinaPTC200 PeltierThermalCycler(MJResearch)using15cyclesof95◦Cfor 30s,55◦Cfor30s,and72◦Cfor30sforthe18SrRNA,usedasinter- nalreferenceand30cyclesformt-1andmt-2,sod1andsod2,cat, enos,ho-1andho-2mRNAs,respectively.Theamplifiedproducts weredetectedona2%agarosegel.TherelativelevelsofmRNAsare expressedasratios(mRNA/18SrRNA).
2.3. Primers
The following primer sets were selected: sod1: F: aagatg- gtgtggccgatgtg and R: ctacagctagcaggataacag; sod2: F: caag- gctcaggttggggttgandR:gctgggatcattagggtagtatg;cat:F:cacagaa- gatggtaactgggandR:ggcgatgtccatctggaatc;enos:F:cactgagcccgtg- gcagtagandR:ggcaggcagcgccaccgacg;mt-1:F:atggaccccaactgctc- ctg and R: gttcccacatcaggcacagc; mt-2: F: atggaccccaactgctcctg and R:cggtcacggtcagggttgtac;ho-1: F:gctgctggtggcccacgcttand R: ctctggtccttggtgtcatgg; ho-2: F: tggcccacgcatacacccgc and R:
ggtctctctggccagtgtgga.Forthenormalizationofsods,cat,enos,mts andhosmRNAs,thelevelofcarp18SrRNAwasusedasinternal standard, detectedwithprimerpairs F:gaaacggctaccacatccaagg, andR:ccgctcccaagatccaactacg.
2.4. Densitometry
Imagesoftheethidiumbromide-stainedagarosegelsweredig- itizedwithaGDS7500GelDocumentationSystemandanalyzed withtheGelBase/GelBlotTMProGelAnalysisSoftware(UVP).
2.5. Enzymeactivitymeasurement
TheRBCswerehemolysedbytheadditionofdistilledwaterata ratioof1:9.ExceptforSODactivitydeterminations,thealiquotsof thehemolysateswereuseddirectly.Thequantityofproteinwas determinedwithFolin reagent, using bovineserumalbuminas standard[19].Biomate5Double-BeamUV–visphotometerrecor- ding (ThermoSpectronic)wasusedforSOD measurementsand GENESYS10SUV–visspectrophotometer(ThermoScientific)was usedforalltheotherparameters.
SOD(EC1.15.1.1)activitywasdeterminedonthebasisofthe inhibition of the epinephrine–adrenochrome autoxidation [20].
Spectrophotometricmeasurementwascarriedoutat480nm.The resultswereexpressedinU/mgprotein.
CAT(EC1.11.1.6)activitywasdeterminedspectrophotometri- callyat240nmbythemethodofBeersandSizer[21]andspecific
Fig.1.ThelevelsofONOO−,H2O2,lipidperoxidation(TBARS),andtheCATactivity inthecordredbloodcellsofmature,healthyneonates(C)andneonateswithIUGR.
Datawereexpressedasmeans±SEMfrommeasurementson24/56samples.
CATactivitywasexpressedinBergmeyerunits(BU)/mgprotein(1 BU=decompositionof1gH2O2/minat25◦C).
2.6. Lipidperoxidationestimationassay
Thelevelofthiobarbituricacid-reactivesubstances(TBARS)is regardedasanappropriateindicatoroftheextentoflipidperoxi- dation(LPO)[22].LPOwasestimatedbyaTBARSassayat532nm againstablankthatcontainedthethiobarbituricacid(TBA)reagent (0.15g/mLTCA,3.75×10−3g/mLTBAand0.25MHCl)asdescribed bySerbinovaetal.[23].
2.7. DeterminationofH2O2production
FortheassayofH2O2,0.05mg/mLhorseradishperoxidaseand 0.1mg/mLo-dianisidineinsodiumphosphatebuffer(100mM,pH 6.5) was used. The H2O2 concentration was determined spec- trophotometrically at 400nm and was calculated as nmol/mg protein[24].
2.8. DeterminationofONOO−production
ONOO−wasassayedbydilutingsamplesinto1.0MNaOH(60:1) andmeasuringtheincrease inabsorbanceat302nm.Asacon- trol,sampleswereaddedto100mMpotassiumphosphate(pH7.4) (60:1).ThedecreaseinabsorbancewasmeasuredatneutralpHas ONOO−decomposes[25]
2.9. Statisticalanalysis
Statisticaldifferenceswerecalculatedwithone-wayanalysis ofvariance(ANOVA)(MedCalcStatisticalSoftwareversion9.4.2.0,
Fig.3.FoldofchangeinthelevelsofONOO-,H2O2,lipidperoxidation(TBARS),and theCATactivityinthecordredbloodcellsofmatureandprematureneonateswith IUGR.Fornormalizationthelevelsofmature,healthyneonateswereusedasrefer- ence.Significantdifferencewasacceptedata/bp≤0.05.(a)Asignificantdifference betweenthemature,healthyneonatesandneonateswithIUGR.(b)Asignificant differencebetweenthematureandprematureneonateswithIUGR.
Broekstraat,Belgium)withaStudent–Newman–Keuls follow-up test.Significantdifferencewasacceptedata,bp≤0.05,aap≤0.01 andaaap≤0.001.
3. Results
3.1. Comparativestudiesofmature,healthyneonatesand neonateswithIUGR
Thelevelsofoxidantmolecules(H2O2andONOO−)andthio- barbituricacid-reactivesubstances(TBARS)andtheactivityofthe H2O2-degradingCATdidnotdiffersignificantlybetweentheIUGR andcontrolgroups(Fig.1).
AsconcernsthemRNAlevelsofgenescodingforantioxidant molecules, significantly lower amounts were measured for cat (∼20%),ho-1(∼40%)andho-2(∼50%)intheIUGRgroupthaninthe controls.Themt-2mRNAlevelwasapproximately1.5-foldhigher intheneonateswithIUGRthaninthecontrolgroup(Fig.2).As aconsequenceoftherelativelyhighindividualfluctuations,the averagesoftheamountsofmt-1,sodsandenosmRNAdidnotdiffer significantly(Fig.2).
3.2. Comparativestudiesofmatureandprematureneonateswith IUGR
TherewasnosignificantdifferenceinthelevelofH2O2orthe activityofCATbetweenthematureandpre-termneonateswith IUGR.However,thematuregroupexhibiteda1.5-foldhigheraccu- mulationofONOO−,andalsoahigherTBARSlevel(Fig.3).Thelevels ofONOO− andTBARSforthepre-termIUGRneonateswerewas moresimilartothoseforthenormalcontrols.
2 2.5
Relative level of mRNA
C IUGR
mt-1 mt-2 ho-1 ho-2 sod-2 sod-1 cat enos a
a
aa
aa C
IUGR C IUGR
0 0.5 1 1.5
C IUGR
Fig.2. mRNAexpressionlevelofantioxidantgenesinthecordredbloodcellsofmature,healthyneonates(C)andneonateswithIUGR.Fornormalizationthelevelof18S rRNAwasusedasaninternalstandard.Datawereexpressedasmeans±SEMfrommeasurementson24/28samples.ap<0.05,aap<0.01.1.
mt-1 mt-2 ho-1 ho-2 sod-2 sod-1 cat enos 0
0.5 1 1.5 2 2.5 3 3.5 4.5
Fold of induction
mature IUGR
premature IUGR ab
aa aa
b aaa
b
a
aa aa mature IUGR
premature IUGR ab
aa
b aaa
b
a
aa aa mature IUGR
premature IUGR ab
aa
b aaa
b
a
aa aa 4
mature IUGR
premature IUGR ab
aa
b aaa
b
aa aa mature IUGR
premature IUGR ab
aa
b aaa
b
aa aa mature IUGR
premature IUGR ab
aa
b aaa
b
aa aa mature IUGR
premature IUGR ab
aa
b aaa
b
aa aa mature IUGR
premature IUGR ab
aa
b aaa
b
aa aa mature IUGR
premature IUGR ab
aa
b aaa
b
aa aa mature IUGR
premature IUGR ab
aa
b aaa
b
aa aa mature IUGR
premature IUGR ab
aa
b aaa
b
aa aa
Fig.4. FoldofchangesinthemRNAlevelsofantioxidantgenesinthecordredbloodcellsofmatureandprematureneonateswithIUGR.Levelsofmature,healthyneonates wereusedasreferences.Significantdifferencewasacceptedata,bp≤0.05,aap≤0.01,aaap≤0.001.(a)Asignificantdifferencebetweenthemature,healthyneonatesand neonateswithIUGR.(b)AsignificantdifferencebetweenthematureandprematureneonateswithIUGR.
MarkeddifferenceswerealsoobservedbetweenthemRNAlev- elsofselectedparametersinthegroupsofmatureandpremature IUGRneonates.Therewasa∼60%differenceinthelevelofthemt-1 andmt-2mRNAs.ThemRNAlevelsofbothgeneswereapproxi- matelydoubledinthematureIUGRneonatesascompared with thepre-termIUGRsandalsothenormalcontrols(Fig.4A).Thetran- scriptionproductsofthehogeneswereconsiderablylowerinboth IUGRgroups;inthematureIUGRs,thelevelsofho-1andho-2mRNA were∼50%and40%ofthoseforthecontrol.IntheprematureIUGR group,bothmRNAlevelswerelowerby25%,thoughthesechanges werenotsignificant.ThelevelofcatmRNAwaslikewiselowerin bothIUGRgroups:asignificant∼25%decreasesweredetected.The transcriptsofthesodgenesinthematureIUGRgroupwere∼1.5- foldthosemeasuredinthecontrolandprematureIUGRgroups.In theprematureIUGRgroup,theenosmRNAwas∼3-foldthatinthe matureIUGRgroup(Fig.4B).Inthiscase,thematureneonateswith orwithoutIUGRexhibitedsimilarmRNAlevels.
4. Discussion
Since IUGRis postulatedto bea pleiotropic complicationof pregnancy,theidentificationofunitmarkermoleculesorreaction pathwaysconnectedwiththisdisorderposesanumberofdifficul- ties.VariousstudieshavefocusedontheantioxidantstatusofIUGR orprematureneonates,butonlybriefaccountshavebeengivenas concernsthecomparisonofprematureandfull-termneonateswith IUGRfromanyaspect.Themajorfindingofthepresentstudyisthe importanceoftheage-basedgroupingofneonateswithIUGR.Sig- nificantdifferencesinthelevelsofspecificstressmarkersrelative tothecontrolgroupwereobservedonlywhenthefull-termand pre-termIUGRneonatesweregroupedseparately.
Ahigherdegreeofoxidativestresswasdetectedinthecord bloodofmatureIUGRneonatesascomparedwiththecontroland pre-termIUGRgroups;thelevelofONOO−wasalmosttwiceas high,indicatingincreasedO2˙−andNOproduction.Thesimulta- neousgenerationofNOandO2˙−inrelativelyhighconcentrations inthesamecompartmentfavoursproductionofthetoxicreaction productONOO−[17].AlthoughONOO−itselfisnotafreeradical,it isapowerfuloxidant,whosetoxicityismanifestedamongothers inLPO[17]andwhichplaysaroleinthepathophysiologyofIUGR [26].
TheelevatedONOO−andO2˙−levelsinthecordbloodofmature neonateswithIUGRwereclearlyreflectedbyanincreasedlevelof TBARS.NO,however,isaJanus-facedmolecule.Sincetheumbili- calcordbloodvesselslackinnervations,theNOproductioninthe endothelialcellsplaysamajorroleinthelocalcontrolofbloodflow andinoxygendeliverytothefoetus[15].Inthisstudy,wehave
demonstratedasignificantlyhigherlevelofthemRNAofeNOSin thecordbloodsamplesofunderdevelopedneonateswithIUGR.In thesecases,theincreaseineNOSexpressionwasnotparalleledby ONOO−accumulation,suggestinganunalteredlevelofO2˙−.Thisis inaccordwiththefactthattherewerenosignificantdifferencesin theexpressionsofthesodgenes,andtheactivityofSODwasalso unaltered(datanotshown).Additionally,nosignificantchanges wereobservedintheTBARSlevelinthecordbloodofthepremature neonateswithIUGR.Aninsufficientlevelofvasodilatationofthe umbilicalvesselsandreducedeNOSactivitywereearlierreported tobeassociatedwithneonateswhoweresmallforgestationalage [16].
EvidencehasrecentlybeenaccumulatingthatCO,bestknown foritstoxicity,canfunctioninasimilarmannertoNO[27]ormay eveninteractwiththeNO-producingpathway[28].COisformed primarilyasaproductofhemedegradation,whichiscatalysedby theHOs.Theobservationof substantialHOactivityin thecord tissuessupportsthepossibilityoftheaccumulationofCOinsuf- ficientlyhighamountstoplayaroleinfetoplacentalbloodflow regulation[29].Ourstudypresentsevidencethattheexpressions ofthehogenesaremarkedlylowinIUGRneonates(regardlessof thelevelofmaturity)versuscontrols.Thoughthelowexpressions ofbothhogeneswerecharacteristicforbothIUGRgroups,asig- nificantdifferencewasobservedonlyforthefull-termneonates withIUGR.Deficienciesin HO-1 havepreviously beenfoundto beassociatedwithpregnancydisorders,suchasrecurrentmiscar- riages,IUGRandpre-eclampsia[30].Ourresultssupportthis:the lowerexpressionofhoinIUGRneonatesmightresultinadecreased COlevelandunsatisfactoryfetoplacentalbloodflow.Moreoverour datarelatingtotheselectedantioxidantmoleculessuggestthatho couldserveasanindicativemarkerprovidingapossiblelinktothe IUGRphenotype.
ThepresenceofIUGRinfull-termneonateswasaccompaniedby significantlyhigherlevelsofexpressionofbothmtgenes.MT,an importantproteinwhichbindsbivalentmetals,playsasignificant roleinnumerous cellularmetabolicprocesses,suchasinmain- tainingZnandCuhomeostasisandin CdandHgdetoxification.
Additionally,anincreasedMTlevelwasdemonstratedbyZapata etal.in theerythrocytesofpregnantwomen[31].ElevatedMT levelshavebeenattributedtotheproliferationanddifferentiation ofbloodcellsintheprocessoferythropoiesis,theprotectiverole oferythrocytesagainsttheactionoffreeradicals,andincreased levelsofestrogenandprogesterone,hormoneswhichinducethe synthesisofMT[32].Astatisticallysignificantincreaseinthelevel ofMTproteinhasadditionallybeenrevealedin theplasmaand RBCs of pregnantwomen and of theirneonateswith IUGR[4].
ThepossiblephysiologicalfunctionsofMTintheplacentainclude
temporaryZnstorageandregulationoftheZnflowtothefoetus, whilerestrictingtoxicmetaltransfer[33]andprotectionagainst theembryotoxic andteratogeniceffects ofa Zndeficiency [34], whichmaybecausedbycigarettesmoke,alcohol,gestationalinfec- tionandexposuretoenvironmentalcontaminants,includingheavy metalsandendocrinedisrupters[35].
Froman analysisof theparameters relating tothedifferent IUGRgroups,wecanconcludethatfull-termneonateswithIUGR areatespeciallyhighrisk.Pre-termneonates,atgestationalages of33–36weeksdemonstratelessdamageintheintegrityofthe lipidmolecules,asignificantaccumulationoftheharmfuloxidant ONOO−cannotbedetected,andtheexpressionsofgenescodingfor antioxidantmarkersarelessaffected.ThesignificantlylowerLPOin theprematureneonatesmaybecorrelatedwiththedecreasedsen- sitivityoftheRBCstooxygenradicals,orwiththefactthattheRBCs ofprematurenewbornscontainasmallerquantityofunsaturated fattyacids[36].Thisphenotypeisnotwithoutprecedent.TheGSH andNADPHlevelsprovedtobelowerinthosewithgestationalages oflessthan33weeksthaninpre-terminfantswithgestationalages of33–36weeks,andthelevelsofthesemarkerswereaslowinfull- term,small-for-ageinfantsasinpre-terminfantswithgestational agesoflessthan33weeks[7].
5. Conclusions
Ourdatafurnishevidencethatthereisextremeheterogeneityin ROSproductionandintheactivationoftheantioxidantdefencesys- temwithinneonateswithIUGR,whichisbluntedbytheuseofmean measurements.Intergroupingbasedongestationalageandbirth- weight,yieldedevidencethatthemolecularresultsinthepre-term IUGRgroupwereoftensimilartothoseforthemature,appropriate- for-ageneonates.However,thebackgroundoftheIUGRphenotype ispleiotropic,andmeasurementsofvariousantioxidantsprovide onlyapartiallyadequatepictureoftheoverallconditionofthe neonates.Data emergingfromdifferentapproaches tothetopic present evidenceonly of theinvolvement of additionalmarker moleculesinthedevelopmentofIUGRdisorders.Ourstudyindi- catesthatthelevelsofexpressionofthemtandhogenesaregood candidatesthroughwhichtocharacterizetheIUGRphenotype.
Conflictofintereststatement
Theauthorsdeclarethattherearenoconflictsofinterest.
References
[1]FinerN,LeoneT.Oxygensaturationmonitoringforthepreterminfant:the evidencebasisforcurrentpractice.PediatrRes2009;65:375–80.
[2]PerroneS,Tataranno ML,StazzoniG, BuonocoreG.Biomarkers ofoxida- tive stress infetal and neonataldiseases. J Matern FetalNeonatal Med 2012;25:2575–8.
[3]ThorntonJG,HornbuckleJ,VailA,SpiegelhalterDJ,LeveneM.Infantwell- beingat2yearsofageintheGrowthRestrictionInterventionTrial(GRIT):
multicentredrandomisedcontrolledtrial.Lancet2004;364:513–20.
[4]BizonA,Milnerowicz-NabzdykE,ZalewskaM,ZimmerM,MilnerowiczH.
Changesinpro/antioxidantbalanceinsmokingandnon-smokingpregnant womenwithintrauterinegrowthrestriction.ReprodToxicol2011;32:360–7.
[5]KalanithiLE,IlluzziJL,NossovVB,FrisbaekY,Abdel-RazeqS,CopelJA,Norwitz ER.Intrauterinegrowthrestrictionandplacentallocation.JUltrasoundMed 2007;26:1481–9.
[6]BuonocoreG,PerroneS.Biomarkersofoxidativestressinthefetusandnew- born.HaematRep2006;2:103–7.
[7]LeeYS,ChouYH.Antioxidantprofilesinfulltermandpretermneonates.Chang GungMedJ2005;28:846–51.
[8]McFarlandVA,InouyeLS,LutzCH,JarvisAS,ClarkeJU,McCantDD.Biomarkers ofoxidativestressandgenotoxicityinliversoffield-collectedbrownbullhead, Ameiurusnebulosus.ArchEnvironContamToxicol1999;37:236–41.
[9]GeorgeSC,HogmanM,PermuttS,SilkoffPE.Modelingpulmonarynitricoxide exchange.JApplPhysiol2004;96:831–9.
[10]ThibeaultDW.Theprecariousantioxidantdefensesofthepreterminfant.Am JPerinatol2000;4:167–81.
[11]AschnerM,SyversenT,SouzaDO.Metallothioneins:mercuryspecies-specific inductionandtheirpotentialroleinattenuatingneurotoxicity.ExpBiolMed 2006;231:1468–73.
[12]SedlakTW,SnyderSH.Bilirubinbenefits:cellularprotectionbyabiliverdin reductaseantioxidantcycle.Pediatrics2004;113:1776–82.
[13]OtterbeinLE,ChoiAM.Hemeoxygenase:colorsofdefenseagainstcellular stress.AmJPhysiolLungCellMolPhysiol2000;279:1029–37.
[14]Myatt L, BrewerA,Brockman DE. Theactionof nitricoxidein theper- fused human fetal-placental circulation. AmJ Obstet Gynecol 1991;164:
687–92.
[15]FoxSB,KhongTY.Lackofinnervationofhumanumbilicalcord.Animmuno- histologicalandhistochemicalstudy.Placenta1990;11:59–62.
[16]KrauseBJ,PrietoCP,Mu ˜noz-UrrutiaE,SanMartínS,SobreviaL,Casanello P.Roleofarginase-2andeNOSinthedifferentialvascularreactivityand hypoxia-inducedendothelialresponseinumbilicalarteriesandveins.Placenta 2012;33:360–6.
[17]RadiR,PeluffoG,AlvarezMN,NaviliatM,CayotaA.Unravelingperoxynitrite formationinbiologicalsystems.FreeRadicBiolMed2001;30:463–88.
[18]NuwaysirEF,BittnerM,TrentJ,BarrettJC,AfshariCA.Microarraysandtoxico- logy.Theadventoftoxicogenomics.MolCarcinogen1999;24:153–9.
[19]LowryOH,RosebroughEA,FarrAL,RandallRJ.ProteinmeasurementwithFolin phenolreagent.JBiolChem1951;193:265–75.
[20]Misra HP, Fridovich I. Therole ofsuperoxide anionin the autoxidation ofepinephrineandasimpleassayforsuperoxidedismutase. JBiolChem 1972;247:3170–5.
[21]BeersJrRF,SizerIW.Catalaseassaywithspecialreferencetomanometric methods.Science1953;117:710–2.
[22]NogueiraCW,QuinhonesEB,JungEAC,ZeniG,RochaJBT.Anti-inflammatory andantinociceptiveactivityofbiphenyldiselenide.InflammRes2003;52:
56–63.
[23]SerbinovaE,KhwajaS,ReznickAZ,PackerL.Thiocticacidprotectsagainst ischemia-reperfusioninjuryintheisolatedperfusedLangendorffheart.Free RadicRes1992;17:49–58.
[24]VillegasE,GillilandSE.HydrogenperoxideproductionbyLactobacillusdel- brueckiiSubspLactisIat5◦C.JFoodSci1998;63:1070–4.
[25]HuieRE,PadmajaS.ThereactionofNOwithsuperoxide.FreeRadicResCom 1993;18:195–9.
[26]NanettiL,GiannubiloSR,RaffaelliF,CurziCM,VigniniA,MoroniC,etal.Nitric oxideandperoxynitriteplateletlevelsinwomenwithsmall-for-gestational- agefetuses.BJOG2008;115:14–21.
[27]JohnsonRA,KozmaF,ColombariE.Carbonmonoxide:fromtoxintoendoge- nousmodulatorofcardiovascularfunctions.BrazJMedBiolRes1999;32:1–14.
[28]MoncadaS,PalmerRM,HiggsEA.Nitricoxide:physiology,pathophysiology, andpharmacology.PharmacolRev1991;43:109–42.
[29]VremanHJ,WongRJ,KimEC,NabsethDC,MarksGS,StevensonDK.Haem oxygenaseactivityinhumanumbilicalcordandratvasculartissues.Placenta 2000;21:337–44.
[30]ZhaoH,WongRJ,KalishFS,NayakNR,StevensonDK.Effectofhemeoxygenase- 1deficiencyonplacentaldevelopment.Placenta2009;30:861–8.
[31]ZapataCL,SimõesTM,DonangeloCM.Erythrocytemetallothioneininrelation tootherbiochemicalzincindicesinpregnantandnonpregnantwomen.Biol TraceElemRes1997;57:115–24.
[32]KägiJH,SchäfferA.Biochemistryofmetallothionein.Biochemistry1988;27:
8509–15.
[33]GoyerRA,HaustMD,CherianMG.Cellularlocalizationofmetallothioneinin humantermplacenta.Placenta1992;13:349–55.
[34]DavisSR,CousinsRJ.Metallothioneinexpressioninanimals:aphysiological perspectiveonfunction.JNutr2000;130:1085–8.
[35]McAleer MF, TuanRS.Cytotoxicant-induced trophoblast dysfunction and abnormalpregnancyoutcomes:roleofzincandmetallothionein.BirthDefects ResCEmbryoToday2004;72:361–70.
[36]VargaSI,NovákZ,PatakiL,PatocskaiM,MatkovicsB.Theinfluenceofantioxi- dantsontheoxidativestressofredbloodcells.ClinChimActa1992;205:241–4.